Friday 29 Mar 2024
By
main news image

SINGAPORE (Dec 20): Singapore’s healthcare sector is expected to face strong pricing competition from neighbouring countries, such as Malaysia and Thailand where patients are able to also receive quality medical treatment at a faction of the cost as compared with Singapore, due to the much lower treatment, drug and room costs.

Furthermore, the SGD’s strength compared to the other key regional countries adds to the pressure on costs, weakening Singapore’s appeal to medical tourists.

Hence, RHB is maintaining its “Neutral” recommendation on...(click on link for full story on theedgesingapore.com)

      Print
      Text Size
      Share